Barclays
CURE icon

Barclays’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Barclays’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$25.1K – 4950
2024
Q1 		$25.1K Hold
200
– – ﹤0.01% 4729
2023
Q4 		$20.3K Hold
200
– – ﹤0.01% 4904
2023
Q3 		$17.7K Hold
200
– – ﹤0.01% 4205
2023
Q2 		$20K Hold
200
– – ﹤0.01% 4134
2023
Q1 		$19.2K Hold
200
– – ﹤0.01% 4664
2022
Q4 		$23K Hold
200
– – ﹤0.01% 4779
2022
Q3 		$17K Hold
200
– – ﹤0.01% 4114
2022
Q2 		$21K Buy
200
+100
+100% +$11.3K ﹤0.01% 4372
2022
Q1 		$13K Buy
+100
New +$11.9K ﹤0.01% 4546
2021
Q4 		– Sell
-1,663
Closed -$179K – 4204
2021
Q3 		$179K Buy
1,663
+1,158
+229% +$139K ﹤0.01% 3673
2021
Q2 		$53K Buy
+505
New +$48.5K ﹤0.01% 4096

Other funds holding CURE

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
BIM
Bullseye Investment Management Cincinnati, Ohio $164M AUM 8.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EWM
Elevatus Welath Management Victor, New York $191M AUM 49.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RC
Rovin Capital Mesa, Arizona $377M AUM 13.67% 1-Year Est. Return
SWM
StoneCrest Wealth Management Chandler, Arizona $313M AUM 57.57% 1-Year Est. Return

Barclays's CURE Position: Q2 2024 in Review

Barclays sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2024, closing a stake of 200 shares — an estimated $25.1K sold.

Barclays first reported a position in CURE in Q2 2021 and held it in 11 quarters. The position peaked at $179K in Q3 2021. 21 funds tracked by Wall St. Rank hold CURE as of Q2 2024.

  • Barclays reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q2 2024 after selling out during the quarter.
  • Barclays sold 200 Direxion Daily Healthcare Bull 3X ETF shares in Q2 2024, an estimated $25.1K.
  • Barclays first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2021 and held it in 11 quarters.
  • Barclays's Direxion Daily Healthcare Bull 3X ETF position peaked at $179K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.